Live Feed

Board of Directors appoints Julie Kim as Representative Director, President & CEO following shareholder vote Announces new appointments and assignments of directors   In the final step of its 18-month CEO transition, Takeda ((4502, NYSE:TAK) today announced that Julie Kim was officially appointed Takeda’s Representative Director, President and Chief Executive Officer. During the 150th Annual General Meeting of Shareholders, which took place in Osaka, Japan, shareholders elected Julie as a new internal director to the Board of Directors. Following the vote and conclusion of the meeting, the Board of Directors appointed her as Representative Director, President & CEO. Upon conclusi

First PMDA-approved molecular residual disease (MRD) test in Japan, supporting the use of Signatera in the adjuvant setting Commercial launch expected by year-end, pending final reimbursement and pricing Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and precision medicine, today announced that Signatera has received regulatory approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA). This approval supports the use of Signatera for patients with colorectal cancer (CRC) in the adjuvant setting and makes Signatera the first PMDA-approved MRD test in Japan. Natera expects to commercially launch Signatera for CRC in Japan by the end of 2026, subject to final p

New research calls on agencies and CMOs to shift their focus from AI-driven cost savings to preserving creativity and differentiation in the AI era According to Forrester’s (NASDAQ:FORR) The State Of AI Inside US Marketing Agencies, 2026, a new report released today in partnership with 4As, AI is now pervasive across US marketing agencies: Nine in 10 agencies use generative AI, and half use agentic AI for marketing execution. Yet rapid adoption, combined with an industrywide focus on productivity and cost efficiency, is undermining marketing effectiveness, creativity, and long-term brand growth. The report further states that enhancing the productivity and impact of staff remains the pr

MSCI Inc. (NYSE:MSCI) is enhancing its global physical climate risk capabilities with the acquisition of First Street, a leading provider of physics-based climate risk data and analytics for every property in the world. Investors, financial institutions and companies are demanding physical climate risk insights embedded directly into investment and risk workflows to inform critical financial decision making, as climate-related physical risks accelerate globally. First Street’s own research shows that companies have become more than 6.5 times as likely to issue profit warnings following extreme weather events in the past two decades.i The integration of First Street’s data and tools into

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.4 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE") AND DOES NOT CONSTITUTE A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CODE. THERE CAN BE NO CERTAINTY THAT ANY FIRM OFFER WILL BE MADE.SAN FRANCISCO, June 24, 2026 /PRNewswire/ -- Prologis, Inc. ("Prologis") announces that on 16 June 2026 it sent a letter to the Board of SEGRO plc ("SEGRO") setting out the terms of an indicative all-share proposal, pursuant to

WISeKey and Its Subsidiary WISeSat.Space Corp. Announce Filing of Registration Statement on Form F-4 with the U.S. Securities and Exchange Commission Canton of Zug, Switzerland— June 24, 2026 — WISeKey International Holding Ltd. ("WISeKey") ((SIX: WIHN, NASDAQ:WKEY), a global leader in cybersecurity, digital identity and IoT, and its subsidiary WISeSat.Space Corp. ("WISeSat") today announced the filing of a registration statement on Form F-4 with the U.S. Securities and Exchange Commission ("SEC") on May 29, 2026 by WISeSat.Space Holdings Corp. ("Pubco"), a wholly-owned subsidiary of WISeSat. The registration statement has not been declared effective by the SEC. The registration statement

Advanced energy prediction platform, Predict+, enables Ukrainian utility to better maintain grid service through demand surges, highly variable weather, and infrastructure disruptions. Tigo Energy, Inc. (NASDAQ:TYGO) ("Tigo" or "Company"), a leading provider of intelligent solar and energy software solutions, today announced that Ukrainian electric utility, YASNO, is the latest enterprise-tier customer to deploy the Tigo Predict+ platform. The AI Energy platform empowers utility operators to adapt to real-world demand challenges as they balance renewable and baseload generation sources. Predict+ currently manages more than 650 GWh and delivers 97.5% forecast accuracy for utility customers

ZUG, Switzerland, June 23, 2026 – MoonLake Immunotherapeutics (NASDAQ:MLTX) ("MoonLake"), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory skin and joint diseases, today announced the pricing of an underwritten public offering of 9,000,000 Class A ordinary shares at a public offering price per share of $20.00 and, in lieu of Class A ordinary shares to certain investors that so choose, pre-funded warrants to purchase up to 1,000,000 Class A ordinary shares at a public offering price per pre-funded warrant of $19.9999, which equals the public offering price per Class A ordinary share less the $0.0001 per share exercise price of each pre-funded wa

SCHEDULE 13D/A - AleAnna, Inc. (0001845123) (Subject)

4/A - ConnectM Technology Solutions, Inc. (0001895249) (Issuer)

Definium Therapeutics, Inc. (NASDAQ:DFTX) (the "Company" or "Definium"), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced the pricing of an underwritten public offering of 20,588,236 common shares, without par value, at a public offering price of $34.00 per common share. The gross proceeds to Definium from the offering, before deducting underwriting discounts, commissions, and other offering-related expenses, are expected to be approximately $700 million. In addition, Definium has granted the underwriters an option for a period of 30 days to purchase up

4 - Spyre Therapeutics, Inc. (0001636282) (Issuer)

4/A - ConnectM Technology Solutions, Inc. (0001895249) (Issuer)

4 - Aura Minerals Inc. (0001468642) (Issuer)

3/A - Aura Minerals Inc. (0001468642) (Issuer)

4 - DOMO, INC. (0001505952) (Issuer)

4 - DOMO, INC. (0001505952) (Issuer)

4 - DOMO, INC. (0001505952) (Issuer)

4 - Spyre Therapeutics, Inc. (0001636282) (Issuer)

4 - MOTORCAR PARTS OF AMERICA INC (0000918251) (Issuer)